EDITORIAL
Published on 07 Dec 2022
Editorial: Considering plant metabolites and their synthetic derivatives as candidates for the development of drugs against multidrug resistant (MDR) tumors
doi 10.3389/fphar.2022.1108252
- 532 views
- Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
- Research Topics
- Considering Plant Metabolites and Their Synthetic Derivatives as Candidates for the Development of Drugs Directed Against Multidrug Resistant (MDR) Tumors.
Considering Plant Metabolites and Their Synthetic Derivatives as Candidates for the Development of Drugs Directed Against Multidrug Resistant (MDR) Tumors.
3,543
Total downloads
13k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 12 Oct 2022
Parvifloron D-based potential therapy for glioblastoma: Inducing apoptosis via the mitochondria dependent pathway
doi 10.3389/fphar.2022.1006832
- 1,468 views
- 4 citations
ORIGINAL RESEARCH
Published on 12 Oct 2022
The thiophene α-terthienylmethanol isolated from Tagetes minuta inhibits angiogenesis by targeting protein kinase C isozymes α and β2
doi 10.3389/fphar.2022.1007790
- 1,621 views
- 1 citation
ORIGINAL RESEARCH
Published on 19 Sep 2022
Luteolin enhances erlotinib’s cell proliferation inhibitory and apoptotic effects in glioblastoma cell lines
doi 10.3389/fphar.2022.952169
- 2,017 views
- 9 citations
ORIGINAL RESEARCH
Published on 19 Jan 2021
Emodin Inhibits the Proliferation of MCF-7 Human Breast Cancer Cells Through Activation of Aryl Hydrocarbon Receptor (AhR)
doi 10.3389/fphar.2020.622046
- 4,762 views
- 36 citations
Published in
Frontiers in Pharmacology
- Experimental Pharmacology and Drug Discovery
Impact
- 13kTopic views
- 9,003Article views
- 3,543Article downloads